Furthermore, we show that Mboat7, but not Tmc4, loss of function in mice is sufficient to drive NAFLD progression, and show that Mboat7 substrate lipids (LPIs) may be critical mediators of obesity-linked liver disease progression. This evidence concerns the gene TMC4 and metabolic dysfunction-associated steatotic liver disease.